| For: | Ramsey ML, Wellner MR, Porter K, Kirkby SE, Li SS, Lara LF, Kelly SG, Hanje AJ, Sobotka LA. Cystic fibrosis patients on cystic fibrosis transmembrane conductance regulator modulators have a reduced incidence of cirrhosis. World J Hepatol 2022; 14(2): 411-419 [PMID: 35317183 DOI: 10.4254/wjh.v14.i2.411] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v14/i2/411.htm |
| Number | Citing Articles |
| 1 |
Carolena Trocchia, Lauren Lazar, Zachary M. Sellers. Clinical management and outcomes of hepatobiliary disease in the cystic fibrosis transmembrane conductance regulator modulator era. Current Opinion in Gastroenterology 2026; 42(2) doi: 10.1097/MOG.0000000000001148
|
| 2 |
Richard D. Maradiaga, Mitchell L. Ramsey, Stephen E. Kirkby, Lindsay A. Sobotka. The Role of Cystic Fibrosis Transmembrane Conductance Regulator Modulators After Liver Transplantation in Persons With Cystic Fibrosis. ACG Case Reports Journal 2024; 11(1) doi: 10.14309/crj.0000000000001261
|
| 3 |
Nathan Lieu, Bernadette J. Prentice, Penelope Field, Dominic A. Fitzgerald. Trials and tribulations of highly effective modulator therapies in cystic fibrosis. Paediatric Respiratory Reviews 2023; 48 doi: 10.1016/j.prrv.2023.09.001
|
| 4 |
Sara Naimimohasses, Ankit Ray, Eunice Tan, Asher Wiggins, Bima J. Hasjim, Shiyi Chen, Mamatha Bhat. Impact of Cystic Fibrosis Transmembrane Conductance Regulator Modulating Therapies on Liver Transplant Outcomes. Gastro Hep Advances 2026; 5(2) doi: 10.1016/j.gastha.2025.100810
|
| 5 |
Tahne Vongsavath, Kyaw Min Tun, Dwaipayan Mukhopadhyay, Chun-Han Lo, Ashok Singh, Rajan Amin, Patrick Twohig, Sammy Saab, Vignan Manne. Effect of Cystic Fibrosis Transmembrane Conductance Regulator Modulators on Liver Enzymes Among Patients With Cystic Fibrosis: A Systematic Review and Meta-Analysis. Gastro Hep Advances 2025; 4(9) doi: 10.1016/j.gastha.2025.100752
|
| 6 |
Laura Giugliano, Elisabetta Augustoni, Antonio Pizzol, Anna Opramolla, Cristina Chiadò, Anna Zagaria, Irene Esposito, Giulia Roberto, Alice Ponte, Andrea Evangelista, Paola Quarello, Michele Pinon, Pier Luigi Calvo. Impact of cystic fibrosis transmembrane conductance regulator modulator therapies on liver stiffness and liver enzymes: An observational perspective single‐center cohort study. JPGN Reports 2026; doi: 10.1002/jpr3.70186
|
| 7 |
Vania L. Kasper, David N. Assis. Pathophysiology of Cystic Fibrosis Liver Disease. Pediatric Pulmonology 2024; 59(S1) doi: 10.1002/ppul.26869
|
| 8 |
Shruti Sakhuja, Heather M. Staples, Charles G. Minard, Louise E. Ramm, Peter J. Lewindon, Grant A. Ramm, Daniel H. Leung. Risk factors for more rapid progression of severe liver fibrosis in children with cystic fibrosis‐related liver disease: A multi‐center study validated by liver biopsy. Liver International 2023; 43(6) doi: 10.1111/liv.15572
|
| 9 |
Zachary M. Sellers, David N. Assis, Shruti M. Paranjape, Meghana Sathe, Frank Bodewes, Melissa Bowen, Marco Cipolli, Dominique Debray, Nicole Green, Kara S. Hughan, William R. Hunt, Julio Leey, Simon C. Ling, Giuseppe Morelli, Daniel Peckham, Rebeca S. Pettit, Alexander Philbrick, Janis Stoll, Kay Vavrina, Stacy Allen, Tara Goodwin, Sarah E. Hempstead, Michael R. Narkewicz. Cystic fibrosis screening, evaluation, and management of hepatobiliary disease consensus recommendations. Hepatology 2024; 79(5) doi: 10.1097/HEP.0000000000000646
|
| 10 |
Charlotte Mouliade, Lucia Parlati, Stylianos Tzedakis, Mathis Collier, Samir Bouam, Anais Vallet-Pichard, Valérie D’Halluin-Venier, Reem Kanaan, Stanislas Pol, Philippe Sogni, Pierre-Régis Burgel, Vincent Mallet. Cystic fibrosis liver disease progression in the era of elexacaftor–tezacaftor–ivacaftor. JHEP Reports 2025; 7(10) doi: 10.1016/j.jhepr.2025.101512
|
| 11 |
Sankalp Malhotra, J. Madison Hyer, Djhenne Dalmacy, Don Hayes, Dmitry Tumin, Stephen E Kirkby, Daniel E Jonas, Seuli Bose-Brill, Susan S. Li. Preventive service utilization among adults with cystic fibrosis covered by private insurance is comparable to the general population. Journal of Cystic Fibrosis 2024; 23(2) doi: 10.1016/j.jcf.2023.11.013
|
| 12 |
Benjamin J. Wilkins, Kathleen M. Loomes. Pathology of Pediatric Gastrointestinal and Liver Disease. 2024; doi: 10.1007/978-3-031-62589-3_11
|
| 13 |
Anatasiya E. Krasnovidova, Olga I. Simonova, Vera P. Chernevich, Aleksandr V. Pakhomov, Aleksandra P. Reykh, Aleksandr A. Pushkov. Genotype-phenotype correlation in siblings with cystic fibrosis. Russian Pediatric Journal 2023; 26(3) doi: 10.46563/1560-9561-2023-26-3-159-167
|